News

In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community ...
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...
Cedric Sturdevant woke up with “a bit of depression” but made it to church, as he does every Sunday. In a few days, he would drive from Mississippi to Washington, D.C., to join HIV advocates at an ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Chicagoland research labs and community clinics are navigating illegal funding stoppages, censorship, and increasing ...
The heads of national HIV organizations have stepped up their advocacy, asking Congress to oppose cuts in President Donald ...
The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...
The US has approved lenacapavir for HIV prevention. But experts worry that cuts to the health budget will 'squander' the drug's chance of reducing infections.
The administration’s proposed budget for HIV prevention represents a 78 percent reduction compared to last fiscal year.
The rates of new HIV infections in Houston and Harris County are higher than the national average. National HIV Testing Day is Friday, June 27th and it's a great reminder to get tested and know your ...
HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...